Search hospitals > Kentucky > Louisville

University of Louisville

Claim this profile
Louisville, Kentucky 40202
Global Leader in Crohn's Disease
Global Leader in Stroke
Conducts research for Gastroparesis
Conducts research for Heart Failure
Conducts research for Gastric Stasis
476 reported clinical trials
41 medical researchers
Photo of University of Louisville in LouisvillePhoto of University of Louisville in Louisville

Summary

University of Louisville is a medical facility located in Louisville, Kentucky. This center is recognized for care of Crohn's Disease, Stroke, Gastroparesis, Heart Failure, Gastric Stasis and other specialties. University of Louisville is involved with conducting 476 clinical trials across 660 conditions. There are 41 research doctors associated with this hospital, such as Neal E. Dunlap, Rebecca Redman, MD, Robert C. Martin, MD,PhD,FACS, and Gerald W Dryden, MD, Ph.D.

Top PIs

Clinical Trials running at University of Louisville

Heart Failure
Stroke
Parkinson's Disease
Crohn's Disease
Liver Cancer
Pancreatic Cancer
Spinal Cord Injury
Atrial Fibrillation
Hepatocellular Carcinoma
Inflammatory Bowel Disease
Image of trial facility.

Reprieve System

for Heart Failure

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Pulmonary Artery Sensor

for Heart Failure

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial). The study contains of 5 arms: NYHA II Cohort - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class II HF patients, where patients have daily access to PAP data. * Treatment Arm (Group 1) * Active Control Arm (Group 2) * Crossover Arm (Group 3) NYHA III Cohort - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class III HF patients, where patients have daily access to PAP data, including a randomized sub-study to evaluate a clinician-directed patient self-management strategy.
Recruiting1 award N/A10 criteria
Image of trial facility.

Ziltivekimab

for Heart Failure

This trial is testing ziltivekimab to see if it can help people with heart failure and inflammation by reducing inflammation and improving heart function.
Recruiting1 award Phase 37 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Louisville?
Where is University of Louisville located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Louisville accept?
What awards or recognition has University of Louisville received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security